Founded
31 Dec 2002
Website
VCID: 368064
Profile
Corporate information
Official name
OpGen Incorporated
Registration country
Official name
OpGen Incorporated
Registration country
Investment activity status
Active investor
Company type
Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets.Funding
Funding rounds
(1 Mar 2012)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | United States |
(1 Mar 2012)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Highland Capital Partners LLC | Global venture capital firm with offices in Boston, Silicon Valley, and San Francisco. | United States |
(1 Mar 2012)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Harris & Harris Group Inc | Internally managed venture capital company specializing in nanotechnology and microsystems | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Versant Ventures Management LLC | Venture capital firm focused on making investments in the healthcare and biotechnology industries. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
CHL Medical Partners Venture capital firm focused on early-stage healthcare sectors. |
+1 (203) 324-7700 |
N/A |
|
Cross Creek Capital LP |
+1 (801) 415-5525 |
Series C |
|
|
Harris & Harris Group Inc Internally managed venture capital company specializing in nanotechnology and microsystems |
+1 (212) 582-0900 |
Series C |
|
|
Highland Capital Partners LLC Global venture capital firm with offices in Boston, Silicon Valley, and San Francisco. |
Series C | |
|
Mason Wells Biomedical Fund I |
+1 (414) 727-6400 |
Series A |
|
|
Versant Ventures Management LLC Venture capital firm focused on making investments in the healthcare and biotechnology industries. |
+1 (949) 729-4500 |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
|
BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. |
United States | 22 Mar 2012 | N/A Active |